Current and future therapies for the medical management of secondary hyperparathyroidism

Seminars in Dialysis

Volumn 11, Issue 5, 1998, Pages 267-270

  Chertow, Glenn M ^a,c   Martin, Kevin J ^b  

^a UCSF Medical Center at Parnassus   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000147492     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139x.1998.tb00363.x     Document Type: Article

References (8)

1. Slatopolsky E, Lopez-Hilker Delmez J, Dusso A, Brown A, Martin KJ: The parathyroid-calcitriol axis in health and chronic renal failure. Kidney Int 29 (Suppl):S41-S47, 1986
2. Gonzalez EA, Martin KJ: Renal osteodystrophy: Pathogenesis and management. Nephrol Dial Transplant 3:13-21, 1995
3. Piraino B, Chen T, Cooperstein L, Segre G, Puschett J: Fractures and vertebral bone mineral density in patients with renal osteodystrophy. Clin Nephrol 30:57-62, 1988
4. Rao DS, Shih MS, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoetin in uremia. N Engl J Med 328:171-175, 1993
5. Massry SG, Goldstein DA: Role of parathyroid hormone in uremic toxicity. Kidney Int 8 (Suppl):S39-S42, 1978
6. Bogicevic M, Stefanovic V: Relationship between parathyroid hormone and pituitary-testicular axis in patients on maintenance hemodialysis. Exp Clin Endocrinol 92:357-362, 1988
7. Bro S, Olgaard K: Effects of excess PTH on nonclassical target organs. Am J Kidney Dis 30:606-620, 1997
8. Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M, Ritz E: Subacute infusion of physiologic doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant 12:933-938, 1997